Replimune Announces Dates for Fiscal Fourth Quarter and Year End 2025 Financial Results and ...

Replimune Announces Dates for Fiscal Fourth Quarter and Year End 2025 Financial Results and ...

WOBURN, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that it will host a conference call on Thursday, May 22, 2025 at…

Bridgeline Announces Financial Results for the Second Quarter of Fiscal 2025

WOBURN, MA, May 15, 2025 (Ecnetnews.com) – Bridgeline Digital, Inc. (NASDAQ:BLIN), a leader in AI-powered marketing technology, today announced financial results for its fiscal 2025 second quarter, which ended March 31, 2025. “Our board and executive team led a $2 million capital raise of common stock to accelerate sales,” said Ari Kahn, Bridgeline’s President and Chief Executive Officer. “Our Hawk AI product line has received outstanding demand…